This Article Full Text Full Text (PDF) All Versions of this Article: 50/2/392    most recent HYPERTENSIONAHA.107.092197v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McNiece, K. L. Articles by Portman, R. J. Search for Related Content PubMed PubMed Citation Articles by McNiece, K. L. Articles by Portman, R. J. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure Related Collections Other hypertension Hypertrophy Clinical Studies

(Hypertension. 2007;50:392.)
© 2007 American Heart Association, Inc.

Original Articles

Left Ventricular Hypertrophy in Hypertensive Adolescents

Analysis of Risk by 2004 National High Blood Pressure Education Program Working Group Staging Criteria

Karen L. McNiece; Monesha Gupta-Malhotra; Joshua Samuels; Cynthia Bell; Kathleen Garcia; Timothy Poffenbarger; Jonathan M. Sorof; Ronald J. Portman

From the Department of Pediatrics, Division of Pediatric Nephrology and Hypertension (K.L.M., J.S., C.B., T.P., R.J.P.), and Department of Pediatrics, Division of Pediatric Cardiology (M.G.-M.), School of Medicine, University of Texas, Houston; Wyle Laboratories (K.G.), Houston, Tex; and AstraZeneca Pharmaceuticals, Wilmington, Del (J.M.S.).

Correspondence to Karen L. McNiece, Division of Pediatric Nephrology and Hypertension, University of Texas-Houston, School of Medicine, 6431 Fannin St, MSB 3.124, Houston, TX 77057. E-mail karen.l.mcniece{at}uth.tmc.edu

The National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents recently recommended staging hypertension (HTN) in children and adolescents based on blood pressure severity. The use of blood pressure staging and its corresponding therapeutic approach was examined in this pooled analysis assessing the risk for end-organ damage, specifically left ventricular hypertrophy among hypertensive adolescents stratified by working group criteria. Newly diagnosed hypertensive adolescents and normotensive control subjects similar in age, race/ethnicity, gender, and body mass index completed casual and 24-hour ambulatory blood pressure measurements, M-mode echocardiography, and fasting serum laboratories. Hypertensive subjects had higher insulin and cholesterol but similar glucose levels as compared with control subjects. Among subjects with stage 1 HTN by casual blood pressure, 34% had white-coat HTN as opposed to 15% of stage 2 hypertensive subjects. Of the subjects with normal casual measurements, 20% had HTN by ambulatory monitoring. Subjects with stage 2 HTN by casual measurement alone (odds ratio: 4.13; 95% CI: 1.04 to 16.48) and after 24-hour ambulatory confirmation (odds ratio: 7.23; 95% CI: 1.28 to 40.68) had increased odds for left ventricular hypertrophy. In addition, the risk for left ventricular hypertrophy was similar for subjects with masked and confirmed stage 1 HTN, whereas subjects with white-coat HTN had a risk comparable to normotensive subjects. Thus, recommendations that adolescents with stage 2 HTN by casual measurements alone receive medication initially along with therapeutic lifestyle counseling are reasonable, though ambulatory blood pressure monitoring remains a valuable tool for evaluating children with stage 2 HTN, because >10% have white-coat HTN.

Key Words: hypertension • left ventricular hypertrophy • echocardiography • ambulatory blood pressure monitoring • white-coat hypertension • masked hypertension • adolescents

This article has been cited by other articles:

				A. Jadhav and J. F. Ndisang Heme Arginate Suppresses Cardiac Lesions and Hypertrophy in Deoxycorticosterone Acetate-Salt Hypertension Experimental Biology and Medicine, July 1, 2009; 234(7): 764 - 778. [Abstract] [Full Text] [PDF]

				J. T. Flynn Hypertension in the young: epidemiology, sequelae and therapy Nephrol. Dial. Transplant., February 1, 2009; 24(2): 370 - 375. [Full Text] [PDF]

				S. Javaheri, A. Storfer-Isser, C. L. Rosen, and S. Redline Sleep Quality and Elevated Blood Pressure in Adolescents Circulation, September 2, 2008; 118(10): 1034 - 1040. [Abstract] [Full Text] [PDF]

				E. Urbina, B. Alpert, J. Flynn, L. Hayman, G. A. Harshfield, M. Jacobson, L. Mahoney, B. McCrindle, M. Mietus-Snyder, J. Steinberger, et al. Ambulatory Blood Pressure Monitoring in Children and Adolescents: Recommendations for Standard Assessment: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young and the Council for High Blood Pressure Research Hypertension, September 1, 2008; 52(3): 433 - 451. [Full Text] [PDF]